Benefit of a pharmacist-led intervention for medication management of renal transplant patients: a controlled before-and-after study

od Chambord, Jeremy, Couzi, Lionel, Merville, Pierre, Moreau, Karine, Xuereb, Fabien, Djabarouti, Sarah
Wydane w Ther Adv Chronic Dis (2021)

Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?

od Ollivier, Julien, Carrié, Cédric, d’Houdain, Nicolas, Djabarouti, Sarah, Petit, Laurent, Xuereb, Fabien, Legeron, Rachel, Biais, Matthieu, Breilh, Dominique
Wydane w Antimicrob Agents Chemother (2019)

Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

od Djabarouti, Sarah, Breilh, Dominique, Duffau, Pierre, Lazaro, Estibaliz, Greib, Carine, Caubet, Olivier, Saux, Marie-Claude, Pellegrin, Jean-Luc, Viallard, Jean-François
Wydane 2010

Correction: Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

od Djabarouti, Sarah, Breilh, Dominique, Duffau, Pierre, Lazaro, Estibaliz, Greib, Carine, Caubet, Olivier, Saux, Marie-Claude, Pellegrin, Jean-Luc, Viallard, Jean-François
Wydane 2011

Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases

od Streicher, Caroline, Djabarouti, Sarah, Xuereb, Fabien, Lazaro, Estibaliz, Legeron, Rachel, Bouchet, Stéphane, Greib, Carine, Breilh, Dominique, Pellegrin, Jean-Luc, Viallard, Jean-François
Wydane w Br J Clin Pharmacol (2014)